Featured Research

from universities, journals, and other organizations

What Causes Prolonged Penile Erection In The Absence Of Sexual Interest?

Date:
March 13, 2008
Source:
Journal of Clinical Investigation
Summary:
Priapism (prolonged penile erection in the absence of sexual interest) is common in male individuals with sickle cell disease, a blood disorder characterized by abnormally shaped red blood cells.

Priapism (prolonged penile erection in the absence of sexual interest) is common in male individuals with sickle cell disease (SCD), a blood disorder characterized by abnormally shaped red blood cells.

Priapism is considered a medical emergency because it is associated with decreased blood flow to the erectile tissue, which can result in erectile tissue damage and, subsequently, erectile dysfunction and impotence.

However, the development of effective treatment and prevention approaches has been limited by poor understanding of the molecular mechanisms underlying the condition. Some insight into this has now been provided by Yang Xia and colleagues, at the University of Texas Medical School at Houston, who have shown that male mice lacking the protein ADA, which breaks down the molecule adenosine, exhibit priapism that could be corrected by ADA therapy.

Further analysis indicated that high levels of adenosine induced priapism through stimulation of the A2B adenosine receptor in ADA-deficient mice. As increased adenosine signaling through the A2B adenosine receptor was also shown to contribute to priapism in SCD transgenic mice, which are a well-accepted mouse model of the condition, the authors suggested that approaches to either reduce adenosine levels or block A2B adenosine receptor activation might provide new ways to treat priapism.

Journal reference: Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. Journal of Clinical Investigation. March 13, 2008.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "What Causes Prolonged Penile Erection In The Absence Of Sexual Interest?." ScienceDaily. ScienceDaily, 13 March 2008. <www.sciencedaily.com/releases/2008/03/080313185749.htm>.
Journal of Clinical Investigation. (2008, March 13). What Causes Prolonged Penile Erection In The Absence Of Sexual Interest?. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/03/080313185749.htm
Journal of Clinical Investigation. "What Causes Prolonged Penile Erection In The Absence Of Sexual Interest?." ScienceDaily. www.sciencedaily.com/releases/2008/03/080313185749.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins